Results 11 to 20 of about 5,005 (167)

Cloning of human Type I interferon cDNAs

open access: yesProceedings of the Japan Academy. Series B, Physical and Biological Sciences, 2023
In the late 1970s, crude interferon samples were found to exhibit anti-tumour activity. This discovery led to the interferon as a “magic drug” for cancer patients.
Shigekazu NAGATA
doaj   +1 more source

Rotavirus NSP1 Inhibits Type I and Type III Interferon Induction

open access: yesViruses, 2021
Type I interferons (IFNs) are produced by most cells in response to virus infection and stimulate a program of anti-viral gene expression in neighboring cells to suppress virus replication. Type III IFNs have similar properties, however their effects are
Gennaro Iaconis   +7 more
doaj   +1 more source

Evasion of Type I Interferon by SARS-CoV-2

open access: yesCell Reports, 2020
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and host immune response determine coronavirus disease 2019 (COVID-19), but studies evaluating viral evasion of immune response are lacking. Here, we use unbiased screening
Hongjie Xia   +8 more
doaj   +1 more source

Insights Into Type I and III Interferons in Asthma and Exacerbations

open access: yesFrontiers in Immunology, 2020
Asthma is a highly prevalent, chronic respiratory disease that impacts millions of people worldwide and causes thousands of deaths every year.
Helen E. Rich   +4 more
doaj   +1 more source

Type I interferon: potential therapeutic target for psoriasis? [PDF]

open access: yesPLoS ONE, 2008
BACKGROUND: Psoriasis is an immune-mediated disease characterized by aberrant epidermal differentiation, surface scale formation, and marked cutaneous inflammation.
Yihong Yao   +10 more
doaj   +1 more source

The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives

open access: yesBiomolecules, 2021
There is a great deal of evidence pointing to interferons (IFNs) as being key cytokines in the pathogenesis of different systemic autoimmune diseases, including primary Sjögren’s syndrome (pSS).
Nicoletta Del Papa   +8 more
doaj   +1 more source

Plasmacytoid Dendritic Cells Mediate Myocardial Ischemia/Reperfusion Injury by Secreting Type I Interferons

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background We previously demonstrated that ischemically injured cardiomyocytes release cell‐free DNA and HMGB1 (high mobility group box 1 protein) into circulation during reperfusion, activating proinflammatory responses and ultimately exacerbating ...
Lina Lai   +5 more
doaj   +1 more source

Antiproliferative Properties of Type I and Type II Interferon

open access: yesPharmaceuticals, 2010
The clinical possibilities of interferon (IFN) became apparent with early studies demonstrating that it was capable of inhibiting tumor cells in culture and in vivo using animal models.
Joseph Bekisz   +4 more
doaj   +1 more source

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation

open access: yesJournal of Experimental & Clinical Cancer Research, 2021
Background Improvement of radiotherapy efficacy requires better insight in the dynamic responses that occur during irradiation. Here, we aimed to identify the molecular responses that are triggered during clinically applied fractionated irradiation ...
Ruben S. A. Goedegebuure   +15 more
doaj   +1 more source

Phleboviruses and the Type I Interferon Response

open access: yesViruses, 2016
The genus Phlebovirus of the family Bunyaviridae contains a number of emerging virus species which pose a threat to both human and animal health. Most prominent members include Rift Valley fever virus (RVFV), sandfly fever Naples virus (SFNV), sandfly ...
Jennifer Deborah Wuerth   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy